知镜 Cognispect · 医学文献与研究工作台

CYB2-knockout Saccharomyces cerevisiae exerts effective antibacterial activity via lactic acid accumulation.

Cong L, Sun N, Zhang Y, Mao S, Wang L, Han Z, Chen C, Ji S, Xie Z, Zhu Z, Li Y.
Virulence · 2026-11-12 · PMID 43016349

文献摘要

Bacterial infectious diseases pose a major threat to human health, and rising antibiotic resistance has complicated treatment. Probiotics are promising alternatives, but their mechanisms remain largely unclear. Here, we screened a randomly selected subset of 1,733 strains from the homozygous diploid Saccharomyces cerevisiae gene-knockout collection (YKOC) and identified CYB2-knockout (CYB2-KO) S. cerevisiae as a strain with potent antibacterial activity. CYB2-KO S. cerevisiae effectively inhibited the growth of pathogenic bacteria, including multidrug-resistant strains, and suppressed biofilm formation by reducing bacterial adhesion, EPS production, and cell surface hydrophobicity. It also increased bacterial cell wall and membrane permeability. The strain showed no hemolytic activity, tolerated acidic conditions and high bile salt concentrations, and exhibited superior auto-aggregation and co-aggregation with pathogenic bacteria. In mouse models of urinary tract infection and enteritis, CYB2-KO S. cerevisiae increased survival and reduced bacterial counts in the bladder, ileum, colon, and cecum. Mechanistically, CYB2 deletion led to lactic acid (LA) accumulation and environmental acidification. Dose-response experiments with exogenous LA, pH neutralization, and supplementation of BY4743 CFS with LA at the CFS-equivalent concentration provided direct causal evidence that LA is the key effector metabolite. These findings highlight CYB2-KO S. cerevisiae as a promising probiotic candidate with broad-spectrum antibacterial activity, with LA accumulation as the primary mechanism underlying its therapeutic effects.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。